Feedback
  • Article / Essay
  • Editorial: Pharmacoeconomics in the era of health technology assessment…

Editorial: Pharmacoeconomics in the era of health technology assessment and outcomes research to prioritize resource use, innovation and investment

Affiliation
Division of Clinical Pharmacology ,Department of Laboratory Medicine and Pathology ,Faculty of Medicine ,Lausanne University Hospital ,University of Lausanne ,Lausanne ,Switzerland
Girardin, François R.;
Affiliation
Division of Clinical Pharmacology ,Department of Medicine ,University of Cape Town ,Cape Town ,South Africa
Cohen, Karen;
Affiliation
Institute of Pharmaceutical Medicine (ECPM) ,University of Basel ,Basel ,Switzerland
Schwenkglenks, Matthias;
Affiliation
Université Paris Est Créteil ,AP-HP URCEco Hôtel Dieu ,Paris ,France
Durand-Zaleski, Isabelle

Preview

Category

Published in:
Frontiers in Pharmacology  
Vol. 14 (16.05.2023)
Volume:
14
Date Issued:
16.05.2023
DOI:
10.3389/fphar.2023.1210002
Language:
English
Type of Resource:
Text
Keywords:
pharmacoeconomics; health technology assessment (HTA); patient related outcome; disinvestment choices; cost-effectiveness
DDC subject of DNB:
610 Medical sciences Medicine

Cite

Citation style:
Could not load citation form.

Access Statistic

Total:
Downloads:
Abtractviews:
Last 12 Month:
Downloads:
Abtractviews:
open graphic

Rights

License Holder: Copyright © 2023 Girardin, Cohen, Schwenkglenks and Durand-Zaleski.

Use and reproduction: